Biotechnology Stocks I Performance Guide: Ginkgo Bioworks Holdings, Inc. (DNA)
DNA has no dividends
Table and Chart of DNA Performance
See what a $1,000 investment in DNA is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| DNA Returns | |
|---|---|
| Start Date | May-28-2021 |
| Start Price | $9.87 |
| End Date | Dec-01-2023 |
| End Price | $1.43 |
| # Prices | 32 |
| Min Date | Apr-28-2023 |
| Min Price | $1.22 |
| Max Date | Oct-29-2021 |
| Max Price | $13.82 |
| Total Return | -85.51% |
| Annualized Return | -51.54% |
| Current Value of $1,000 Purchase | $145 |
| Number Returns | 496 |
| Average Return | -44.23% |
| Number Profitable Returns | 66 |
| Percent Profitable Returns | 13.31% |
| Number Unprofitable Returns | 430 |
| Percent Unprofitable Returns | 86.69% |
| Profitable to Unprofitable Returns Ratio | 0.15 |
| DNA Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $3,029,369,000 | Price to Sales | 9.62 |
| Earnings per Share | $-0.4100 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 2.418 |
| PRICE DATA | |
| 52 Week High | $2.545 |
| 52 Week Low | $1.12 |
| Analyst Target Price | $3.38 |
| 50-Day Moving Average | $1.547 |
| 200-Day Moving Average | $1.636 |
| FINANCIAL DATA | |
| Revenue per Share | $0.165 |
| Revenue | $314,985,000 |
| Profit Margin | -272% |
| Return on Equity | -0.635% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
DNA Compare Returns with S&P 500
DNA Trendline Chart